Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis

Journal of Investigative Dermatology

Volumn 131, Issue 3, 2011, Pages 677-687

  Chiricozzi, Andrea ^a,b   Guttman Yassky, Emma ^a,c   Suárez Farĩas, Mayte ^a   Nograles, Kristine E ^a   Tian, Suyan ^a   Cardinale, Irma ^a   Chimenti, Sergio ^b   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; UPREGULATION;

EID: 79951512605     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.340     Document Type: Article

References (49)

1. Abraham C, Cho J (2009) Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15:1090-100
2. Albanesi C, Cavani A, Girolomoni G (1999) IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 162:494-502 (Pubitemid 29018959)
3. Banno T, Gazel A, Blumenberg M (2004) Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279:32633-42 (Pubitemid 39014721)
4. Boniface K, Diveu C, Morel F et al. (2007) Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 178:4615-22 (Pubitemid 46492414)
5. Chamian F, Lowes MA, Lin SL et al. (2005) Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-80 (Pubitemid 40262014)
6. Crome SQ, Wang AY, Levings MK (2010) Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 159:109-19
7. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-50
8. Elder JT (2009) Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun 10:201-9
9. Fantuzzi F, Del Giglio M, Gisondi P et al. (2008) Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. Expert Opin Ther Targets 12:1085-96
10. Gaffen SL (2009) The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep 11:365-70
11. Gottlieb AB, Chamian F, Masud S et al. (2005) TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175:2721-9 (Pubitemid 41113889)
12. Gudjonsson JE, Ding J, Li X et al. (2009) Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 129:2795-804
13. Guilloteau K, Paris I, Pedretti N et al. (2010) Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis. J Immunol; e-pub ahead of print 24 March 2010
14. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J et al. (2007) Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 119:1210-7 (Pubitemid 46654193)
15. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J et al. (2008) Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 181:7420-7
16. Harper EG, Guo C, Rizzo H et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129:2175-83
17. Homey B, Dieu-Nosjean MC, Wiesenborn A et al. (2000) Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-32 (Pubitemid 30408849)
18. Khader SA, Gaffen SL, Kolls JK (2009) Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2:403-11
19. Krueger GG, Langley RG, Leonardi C et al. (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356:580-92 (Pubitemid 46220818)
20. Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(Suppl 2):ii30-6 (Pubitemid 40288517)
21. Lee E, Trepicchio WL, Oestreicher JL et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with Psoriasis vulgaris. J Exp Med 199:125-30 (Pubitemid 38076484)
22. Liang SC, Tan XY, Luxenberg DP et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-9 (Pubitemid 44498362)
23. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-73
24. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-11 (Pubitemid 351543220)
25. Maitra A, Shen F, Hanel W et al. (2007) Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci USA 104:7506-11 (Pubitemid 47185936)
26. Menter A (2009) The status of biologic therapies in the treatment of moderate to severe psoriasis. Cutis 84:14-24
27. Mizgerd JP, Spieker MR, Doerschuk CM (2001) Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol 166:4042-8 (Pubitemid 32224934)
28. Moran EM, Mullan R, McCormick J et al. (2009) Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther 11:R113
29. Morishima N, Mizoguchi I, Takeda K et al. (2009) TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem Biophys Res Commun 386:105-10
30. Mossner R, Reich K (2009) Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab. Curr Probl Dermatol 38:107-36
31. Nair RP, Duffin KC, Helms C et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41:199-204
32. Nair RP, Ruether A, Stuart PE et al. (2008) Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 128:1653-61 (Pubitemid 351847381)
33. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159:1086-91
34. Ortega C, Fernandez AS, Carrillo JM et al. (2009) IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 86:435-43
35. Pelletier M, Maggi L, Micheletti A et al. (2010) Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115:335-43
36. Ruddy MJ, Wong GC, Liu XK et al. (2004b) Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279:2559-67 (Pubitemid 38114241)
37. Russell CB, Kerkof K, Bigler J et al. (2010) Blockade of the IL-17R with AMG 827 leads to rapid reversal of gene expression and histopathologic abnormalities in human psoriatic skin. J Invest Dermatol 130:S46 (abstr.)
38. Shen F, Hu Z, Goswami J et al. (2006) Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281:24138-48 (Pubitemid 44274188)
39. Shen F, Ruddy MJ, Plamondon P et al. (2005) Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 77:388-99 (Pubitemid 40289569)
40. Stockinger B, Veldhoen M, Martin B (2007) Th17 T cells: linking innate and adaptive immunity. Semin Immunol 19:353-61 (Pubitemid 351274048)
41. Suarez-Farinas M, Lowes MA, Zaba LC et al. (2010) Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS One 5:e10247
42. Tesmer LA, Lundy SK, Sarkar S et al. (2008) Th17 cells in human disease. Immunol Rev 223:87-113 (Pubitemid 351986173)
43. Verrier F, Nadas A, Gorny MK et al. (2001) Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6. J Virol 75:9177-86 (Pubitemid 32851922)
44. Watanabe H, Gaide O, Petrilli V et al. (2007) Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127:1956-63 (Pubitemid 47075373)
45. Wilson NJ, Boniface K, Chan JR et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950-7 (Pubitemid 47300009)
46. Yao Y, Richman L, Morehouse C et al. (2008) Type I interferon: potential therapeutic target for psoriasis? PLoS One 3:e2737
47. Zaba LC, Cardinale I, Gilleaudeau P et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-94
48. Zaba LC, Suarez-Farinas M, Fuentes-Duculan J et al. (2009) Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124:1010-22, e1021-1395
49. Zhou X, Krueger JG, Kao MC et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63 100-element oligonucleotide array. Physiol Genomics 13:69-78 (Pubitemid 37129170)